Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
    • Articles
  • Pipeline
    • Overview
    • MT-6402
    • MT-5111
    • MT-0169
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors

Apr 08, 2022 8:00am EDT

Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results

Mar 28, 2022 4:30pm EDT

Molecular Templates Strengthens Board of Directors and Management Team

Mar 02, 2022 8:00am EST

Molecular Templates to Present at the Upcoming Investor Conferences

Mar 01, 2022 8:00am EST

Molecular Templates Provides Corporate Update and Outlines 2022 Milestones

Nov 30, 2021 5:30pm EST

Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402

Nov 18, 2021 8:00am EST

Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results

Nov 15, 2021 7:30am EST

Molecular Templates to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 20, 2021 8:00am EDT

Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results

Aug 12, 2021 4:30pm EDT

Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors

Jul 09, 2021 8:00am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12
    Next
    © 2023 Molecular Templates, Inc. All Rights Reserved.
    Twitter Linkedin
    Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access